Envista Holdings Corporation Common stock, $0.01 par value per share (NVST) is a publicly traded Healthcare sector company. As of May 21, 2026, NVST trades at $23.77 with a market cap of $3.77B and a P/E ratio of 84.71. NVST moved +2.97% today. Year to date, NVST is +5.41%; over the trailing twelve months it is +33.76%. Its 52-week range spans $14.22 to $30.42. Analyst consensus is buy with an average price target of $29.40. Rallies surfaces NVST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Envista Q1 EPS Up 50% to $0.36, $706M Sales Beat and $300M Buyback: Envista reported Q1 net income of $39 million ($0.23 GAAP EPS, $0.36 adjusted EPS), topping consensus by 16 cents and generated $706 million revenue with 9.5% core growth. The company announced a $300 million incremental share repurchase program and reaffirmed full-year adjusted EPS guidance of $1.35–1.45.
| Metric | Value |
|---|---|
| Price | $23.77 |
| Market Cap | $3.77B |
| P/E Ratio | 84.71 |
| EPS | $0.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.42 |
| 52-Week Low | $14.22 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.72B |
| Net Income | $47.00M |
| Gross Margin | 54.67% |
11 analysts cover NVST: 0 strong buy, 6 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.40.